About Us
ProDevLabs is a Premier Wound Care R&D and Preclinical CRO. We are a Full-Service CRO and can help clients navigate the process of commercializing a new product, with 30+ years’ experience in wound repair and regeneration, biologics, biomaterials, medical devices, and pharmaceuticals.
OUR PURPOSE
We believe that we can help grow your company through meaningful and impactful ways. We build trust with our clients through innovation and high caliber science.
OUR STORY
Dr. Mitch Sanders is a Serial Entrepreneur, C-Level Executive, and Scientist developing advanced wound care products for the past 30 years with 20 peer reviewed publications and 45 world-wide patents. Dr. Sanders was founder and CEO of ECI Biotech (1998-2016) and his company developed the first infection diagnostic for chronic wounds (Bacterial Status), sold by WoundChek Labs. Over the past 20 years Dr. Sanders has secured over $65M in strategic partnerships for new product development. Mitch founded ProDevLabs in 2023 with the same team he strategically put together over the past 10 years.
WHAT WE DO
Our suite of services includes:
- Drug & Device Development
- Preclinical Practices
- Intellectual Property Portfolio Management
- New Product Development
- Scale Up Manufacturing
- Biocompatibility
- Regulatory
- Business Development
- Go to Market Strategy
- Technical M&A Advisory Services
Let our expert Scientists and Business Advisors help your team to ensure speed to market and commercial success.